Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 19 September 2008
European Journal of Endocrinology (2008) In press
DOI: 10.1530/EJE-08-0476
Copyright © 2008 by European Society of Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Peppa, M.
Right arrow Articles by Hadjidakis, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peppa, M.
Right arrow Articles by Hadjidakis, D.

CLINICAL STUDY

Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene

Melpomeni Peppa, Eleni Boutati, Vasilios Pikounis, George Peros, Smaragda Kamakari, Ioannis Panayiotides, Theofanis Economopoulos, Sotirios Raptis and Dimitrios Hadjidakis

M Peppa, Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, "Attikon" University Hospital, Athens, Greece, Athens, Greece
E Boutati, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, "Attikon" University Hospital, Athens, Greece, Athens, Greece
V Pikounis, Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, "Attikon" University Hospital, Athens, Greece
G Peros, Fourth Department of Surgery, Athens University Medical School, "Attikon" University Hospital, Athens, Greece, Athens, Greece
S Kamakari, BioGenomica, Center for Genetic Research and Analysis, Athens, Greece, Athens, Greece
I Panayiotides, Second Department of Pathology, Athens University Medical School, "Attikon" University Hospital, Athens, Greece, Athens, Greece
T Economopoulos, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, "Attikon" University Hospital, Athens, Greece, Athens, Greece
S Raptis, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, "Attikon" University Hospital, Athens, Greece, Athens, Greece
D Hadjidakis, Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, "Attikon" University Hospital, Athens, Greece, Athens, Greece

Correspondence: Vasilios Pikounis, Email: bpikounis{at}yahoo.gr

Abstract

Abstract

Introduction : Multiple endocrine neoplasia type 2A is an autosomal dominant hereditary disorder, associated with a cluster of germline gain-of-function mutations of the RET proto-oncogene (RET), mainly in exons 10-15. The G533C mutation in exon 8 of the RET is rare and has been mainly related to the familial medullary thyroid carcinoma (FMTC).

Patients-Methods: We describe the RET G533C mutation in exon 8 of the RET in 2 unrelated female index patients, with MEN2A phenotype, consisting of pheochromocytoma (PHEO) which was the presenting feature and medullary thyroid carcinoma (MTC). In addition, twelve family members were also studied. DNA extraction, polymerase chain reaction (PCR) and sequencing of the RET was performed in exons 7-19 and 21, following standard procedures.

Results: The mutation was found in both index patients and in 6 out of 12 family members (50%). Three of them were biochemically affected with histologically proven MTC in 2 of them while there are not certain clues regarding the other 3 members as they denied further evaluation.

Conclusion: Patients with MEN2A mutations should be also searched in exon 8 while positive carriers of this mutation should be screened annually for PHEO or other components of the syndrome.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 European Society of Endocrinology.